FLT3 inhibitors in acute myeloid leukemia: Choosing the best when the optimal does not exist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FLT3 inhibitors in acute myeloid leukemia: Choosing the best when the optimal does not exist

Published:2018-01-25 Issue:4 Volume:93 Page:553-563
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Assi Rita¹^ORCID,Ravandi Farhad¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Charif Souki Cancer Research Fund and generous philanthropic contributions to the MD Anderson Moon Shots Program

MD Anderson Cancer Centre Support Grant (CCSG)

Publisher

Wiley

Subject

Hematology

Reference108 articles.

1. Molecular pathogenesis of AML: translating insights to the clinic;Levine;Best Pract Res Clin Haematol.,2013

2. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Ley;N Engl J Med.,2013

3. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood.,2002

4. Oncogenic kinase signalling;Blume-Jensen;Nature.,2001

5. Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias;Carow;Blood.,1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party;Clinical Cancer Research;2023-08-21

2. Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level;Frontiers in Immunology;2023-08-10

3. Midostaurin – the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation;Acta Poloniae Pharmaceutica - Drug Research;2023-03-03

4. Advances in Targeted Therapy for Acute Myeloid Leukemia;Nihon Naika Gakkai Zasshi;2022-06-10

5. The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets;Current Medicinal Chemistry;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3